Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First

NCT ID: NCT04096339

Last Updated: 2019-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-03

Study Completion Date

2020-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to compare the effect of different procedural sequences on the time to recovery and the propofol sedation requirements in patients undergoing bidirectional endoscopy with sedation.

The two sequences are:

* Colonoscopy followed by Esophagogastroduodenoscopy (EGD)
* EGD followed by Colonoscopy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

120 patients will be asked to participate in the trial. The subject will undergo both procedures in the order assigned by the randomization sheet. During the procedure, the endoscopist and anesthesiologists will collect data including but not limited to vital signs (heart rate, blood oxygen level, blood pressure) and level of sedation through the Bispectral Index Monitor (BIS). After completing the procedures, the patient will be approached in the recovery room by the study coordinator who will administer the Modified Post Anesthesia Discharge Scoring System (M-PADSS) scale every 5 minutes until a score of 9 or higher is obtained on two consecutive attempts. 24 hours following the procedure, the study coordinator will call the patient in order to assess the patient's cognitive function and drowsiness after they were discharged from the endoscopy unit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia, Recovery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EGD followed by Colonoscopy

Randomized to group Esophagogastroduodenoscopy followed by Colonoscopy

Group Type ACTIVE_COMPARATOR

EGD followed by Colonoscopy

Intervention Type OTHER

Esophagoduodenoscopy (EGD) is done first followed by Colonoscopy

Colonoscopy followed by EGD

Randomized to group Colonoscopy followed by Esophagogastroduodenoscopy

Group Type ACTIVE_COMPARATOR

Colonoscopy followed by EGD

Intervention Type OTHER

Colonoscopy is done first followed by EGD

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colonoscopy followed by EGD

Colonoscopy is done first followed by EGD

Intervention Type OTHER

EGD followed by Colonoscopy

Esophagoduodenoscopy (EGD) is done first followed by Colonoscopy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age above 18
* Scheduled EGD and colonoscopy on the same day
* Scheduled to Anaesthesiologist administered sedation during the procedure

Exclusion Criteria

* Age below 18
* Known allergy or adverse reaction to Propofol, Midazolam or opioid medication (ex: fentanyl)
* Medical contraindication to Anaesthesia
* Sleep apnea
* American Society of Anesthesiologists classification (ASA) \>3
* Inpatient status
* Pregnant or lactating women
* Known cirrhosis
* Chronic Kidney Disease (stage 4 or 5)
* Known psychological disorder
* Known cognitive dysfunction
* Significant gastroparesis
* Gastric outlet obstruction
* Ileus
* Known or suspected bowel obstruction or perforation
* Having a stoma
* Compromised swallowing reflex or mental status
* Prior colon resection or gastric surgery
* Age above 75 years
* Chronic use of more than 1 psychoactive drug (Benzodiazepines, Tricyclic antidepressants, antipsychotics, selective serotonin receptor inhibitors, serotonin norepinephrine receptor inhibitors, Monoamine oxidase inhibitor)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American University of Beirut Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ala'a Sharara, MD

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ala I Sharara, MD

Role: PRINCIPAL_INVESTIGATOR

American University of Beirut Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

American University of Beirut - Medical Center

Beirut, , Lebanon

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ala I Sharara, MD

Role: CONTACT

+961-1-350000 ext. 5345

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ala' I. Sharara, MD

Role: primary

009611350000 ext. 5345

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BIO-2018-0629

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sedation in Patients Undergoing GIT Endoscopy
NCT05880459 UNKNOWN EARLY_PHASE1